Search result for 'janssen'

Lupin launches Rivaroxaban for Oral Suspension (generic Xarelto) in the US. Treats VTE in pediatric patients. Annual sales: USD 11M.

Lupin has received USFDA approval for its generic version of Symtuza, a medication for HIV. The product is estimated to have annual sales of USD 1.374 billion in the US.

Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated for treating schizophrenia. The drug is therapeutically equivalent to...

The Organisation of Pharmaceutical Producers of India (OPPI) has appointed Bhushan Akshikar as its President for two years. Akshikar brings over 28 years of experience in the pharmaceutical industry.

Biocon Biologics has reached an agreement with Janssen to launch its biosimilar medication for autoimmune diseases in Europe, Canada, and Japan. The settlement clears the way for commercialization...

Glenmark Pharmaceuticals receives USFDA approval to market generic Topiramate Capsules, a medication used for treating and preventing seizures. The drug will be distributed in the US by Glenmark...

Glenmark Pharmaceuticals has received USFDA approval for its generic Topiramate capsules used to treat seizures. The drug is bioequivalent to Topamax capsules.

Biocon Biologics has secured a licence to commercialize its biosimilar product to treat psoriasis, Crohn's disease, and ulcerative colitis in the US.

Aurobindo Pharma receives USFDA approval to market a generic HIV-1 treatment drug, Darunavir tablets, in strengths of 600 mg and 800 mg. The drug is therapeutically equivalent to Prezista tablets.